天新药业
(603235)
| 流通市值：115.49亿 | | | 总市值：115.49亿 |
| 流通股本：4.38亿 | | | 总股本：4.38亿 |
| 报告期 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,569,646,261.86 | 1,367,549,220.46 | 1,332,633,102.38 | 1,624,850,171.78 |
| 交易性金融资产 | - | 157,771,072.27 | 158,073,538.02 | 10,002,949.28 |
| 应收票据及应收账款 | 374,795,301.27 | 308,924,475.35 | 328,677,212.87 | 398,123,815.63 |
| 其中：应收票据 | 80,829,805.91 | 72,143,736.23 | 67,116,503.05 | 113,783,352.84 |
| 应收账款 | 293,965,495.36 | 236,780,739.12 | 261,560,709.82 | 284,340,462.79 |
| 应收款项融资 | 85,465,214.44 | 24,386,155.95 | 7,031,517.25 | 11,741,063.73 |
| 预付款项 | 31,382,803.19 | 42,023,349.83 | 17,991,833.36 | 32,397,202.62 |
| 其他应收款合计 | 3,033,478.38 | 3,346,188.51 | 5,263,418.5 | 3,437,480.57 |
| 存货 | 569,886,166.72 | 550,735,359.7 | 601,810,076.43 | 598,817,047.67 |
| 其他流动资产 | 148,600,286.84 | 133,191,086.1 | 119,508,288.79 | 98,494,220.37 |
| 流动资产合计 | 2,782,809,512.7 | 2,587,926,908.17 | 2,570,988,987.6 | 2,777,863,951.65 |
| 非流动资产: | | | | |
| 固定资产 | 2,084,171,028.02 | 1,884,963,170.41 | 1,436,665,306.21 | 1,441,836,826.18 |
| 在建工程 | 1,006,684,460.3 | 1,136,115,713.31 | 1,432,536,158.78 | 1,269,555,876.91 |
| 使用权资产 | 13,603,380.75 | 2,524,478.46 | 3,250,178.48 | 3,975,878.51 |
| 无形资产 | 188,477,795.97 | 189,891,694.77 | 186,979,216.65 | 187,075,756.06 |
| 长期待摊费用 | 14,731,339.17 | 12,621,536.26 | 10,420,231.3 | 9,260,895.23 |
| 递延所得税资产 | 90,899,762.72 | 84,074,686.34 | 85,284,138.98 | 81,826,967.47 |
| 其他非流动资产 | 8,342,976.74 | 36,167,231.29 | 28,673,332.36 | 43,450,981.33 |
| 非流动资产合计 | 3,406,910,743.67 | 3,346,358,510.84 | 3,183,808,562.76 | 3,036,983,181.69 |
| 资产总计 | 6,189,720,256.37 | 5,934,285,419.01 | 5,754,797,550.36 | 5,814,847,133.34 |
| 流动负债: | | | | |
| 短期借款 | 7,328,415.25 | - | 6,700,900 | 15,054,858.73 |
| 应付票据及应付账款 | 312,220,841.5 | 274,363,264.4 | 197,287,911.46 | 255,890,009.62 |
| 应付账款 | 312,220,841.5 | 274,363,264.4 | 197,287,911.46 | 255,890,009.62 |
| 合同负债 | 18,290,685.5 | 11,766,819.31 | 21,631,436.74 | 16,458,150.61 |
| 应付职工薪酬 | 126,040,843.16 | 80,585,975.54 | 62,666,641.22 | 41,020,387.86 |
| 应交税费 | 31,772,817.68 | 31,177,354.32 | 52,001,663.44 | 36,182,622.46 |
| 其他应付款合计 | 14,054,536.06 | 22,743,053.32 | 16,422,401.84 | 11,468,767.59 |
| 一年内到期的非流动负债 | 84,575,056.89 | 26,476,406.71 | 12,532,011.87 | 13,026,395.16 |
| 其他流动负债 | 41,301,930.31 | 25,491,192.28 | 43,251,442.43 | 37,136,605.26 |
| 流动负债合计 | 635,585,126.35 | 472,604,065.88 | 412,494,409 | 426,237,797.29 |
| 非流动负债: | | | | |
| 长期借款 | 299,839,774.71 | 344,702,551.86 | 320,126,570.48 | 200,948,615.28 |
| 租赁负债 | 13,175,725.98 | 740,229.74 | 1,103,816.7 | 1,463,120.04 |
| 递延收益 | 324,602,519.94 | 330,996,497.12 | 340,121,006.6 | 349,260,516.08 |
| 非流动负债合计 | 637,618,020.63 | 676,439,278.72 | 661,351,393.78 | 551,672,251.4 |
| 负债合计 | 1,273,203,146.98 | 1,149,043,344.6 | 1,073,845,802.78 | 977,910,048.69 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 437,780,000 | 437,780,000 | 437,780,000 | 437,780,000 |
| 资本公积 | 2,001,805,366.59 | 2,001,805,366.59 | 2,001,805,366.59 | 1,999,321,360.82 |
| 减:库存股 | 60,014,480.99 | 60,014,480.99 | 60,014,480.99 | 60,014,480.99 |
| 盈余公积 | 218,890,000 | 218,890,000 | 218,890,000 | 218,890,000 |
| 未分配利润 | 2,318,056,223.79 | 2,186,781,188.81 | 2,082,490,861.98 | 2,240,960,204.82 |
| 归属于母公司股东权益合计 | 4,916,517,109.39 | 4,785,242,074.41 | 4,680,951,747.58 | 4,836,937,084.65 |
| 股东权益合计 | 4,916,517,109.39 | 4,785,242,074.41 | 4,680,951,747.58 | 4,836,937,084.65 |
| 负债和股东权益合计 | 6,189,720,256.37 | 5,934,285,419.01 | 5,754,797,550.36 | 5,814,847,133.34 |
| 公告日期 | 2026-04-24 | 2025-10-31 | 2025-08-29 | 2025-04-30 |
| 审计意见(境内) | 标准无保留意见 | | | |